Pacifica Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PR
SGH
Pacifica Partners's XBI Position: Q3 2026 in Review
Pacifica Partners held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 200 shares worth $30.9K. The position accounts for 0.01% of the portfolio, ranked #208.
Pacifica Partners first reported a position in XBI in Q4 2020 and has held it in 24 quarters since. The position peaked at $32.1K in Q2 2026. 261 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Pacifica Partners held 200 shares of State Street SPDR S&P Biotech ETF worth $30.9K as of Q3 2026.
- Pacifica Partners left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 0.01% of Pacifica Partners's portfolio in Q3 2026, its #208 holding.
- Pacifica Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 24 quarters since.
- Pacifica Partners's State Street SPDR S&P Biotech ETF position peaked at $32.1K in Q2 2026.
- 261 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Pacifica Partners's 13F filing for Q3 2026, filed 9 Oct 2026.